A mitochondria-targeting lipid-small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model.

Tang, Menghuan; Lin, Kai; Ramachandran, Mythili; Li, Longmeng; Zou, Hongye; Zheng, Huzhi; Ma, Zhao; Li, Yuanpei

Tang, Menghuan; Lin, Kai; Ramachandran, Mythili; Li, Longmeng; Zou, Hongye; Zheng, Huzhi; Ma, Zhao; Li, Yuanpei.

Afiliação

Tang M; Key Laboratory of Luminescent and Real-Time Analytical Chemistry, Ministry of Education, College of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.
Lin K; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
Ramachandran M; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
Li L; College of Food Science and Engineering, Ocean University of China, Qingdao 266003, China.
Zou H; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
Zheng H; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
Ma Z; Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA 95817, USA.
Li Y; Key Laboratory of Luminescent and Real-Time Analytical Chemistry, Ministry of Education, College of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.

Acta Pharm Sin B ; 12(6): 2672-2682, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35755275

Palavras-chave

Cancer therapy; Drug delivery; Hybrid nanoparticle; Lipid-small molecule nanoparticle; Mitochondria targeting; Orthotopic glioma; Photodynamic therapy; Tumor imaging

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Acta Pharm Sin B Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google